Keyword: National Cancer Institute
The consortium intends to make new tools, models and processes broadly available, with a large focus on solutions geared toward cancer patients.
GlaxoSmithKline is joining forces with Lyell Immunopharma to boost the “fitness” of T cells treatments and improve their efficacy in solid tumors.
A multi-institution research team has made several surprising discoveries about the role of proteins in colon cancer, which could inspire new treatments.
Incoming FDA Commissioner Ned Sharpless used his first official talk to ensure we all know he’s not looking to tear up Scott Gottlieb’s legacy.
NCI Director Ned Sharpless taking on the role of acting head of the FDA raises some intriguing possibilities for interagency cooperation.
Real-world data firm Litmus Health published its first census of wearable devices for clinical research.
An NCI team is reporting promising results from a small trial of a dendritic-cell vaccine in patients whose tumors overexpress HER2.
A team at the National Cancer Institute has discovered how bacteria in the gut affect antitumor immune responses in the liver.
The past week ushered in discoveries related to the genetics of immuno-oncology success, genes and heart failure, and treating Gulf War illness.
President Donald Trump is considering switching up his attack on U.S. health research budgets by capping how much the NIH can spend on indirect costs.